Gilead Brings In Sanofi’s Dietmar Berger To Reset Drug Development

 
• By Andrew McConaghie
  
Gilead
Gilead adds in liver with CymaBay acquisition • Source: Shutterstock: Tada Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Executives On The Move

More from Scrip